Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director
|
|
Arbutus Biopharma Corp (ABUS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/03/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/04/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/06/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
| 03/05/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 03/07/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/16/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 05/17/2017 |
10-K/A
| Annual Report for the period ended March 31, 2017 [amend] |
| 03/22/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 03/10/2016 |
10-K/A
| Annual Report for the period ended December 31, 2015 [amend] |
| 03/09/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 04/30/2015 |
10-K/A
| Annual Report for the period ended December 31, 2014 [amend] |
| 03/13/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/27/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
|
|